An FDA panel supports Merck COVID drug in mixed vote : compa

An FDA panel supports Merck COVID drug in mixed vote

If the Food and Drug Administration authorizes use of the drug, called molnupiravir, it would be the first oral COVID-19 treatment that could be taken at home.

Related Keywords

Lindsey Baden , Nicholas Kartsonis , Ridgeback Biotherapeutics , John Coffin , Janet Cragan , Centers For Disease , Pfizer , Drug Administration , Tufts University , Disease Control ,

© 2025 Vimarsana